Tremfya 100 mg in 1 mL Auto-Injector
RxNorm 2118741
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2118741 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tremfya 100 mg in 1 mL Auto-Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL guselkumab 100 mg/ML Auto-Injector [Tremfya]
(Atom ID: 10825897)
SYPrescribable
Synonym (SY):
1 mL Tremfya 100 mg/ML Auto-Injector
(Atom ID: 10825899)
PSNPrescribable
Prescribable Name (PSN):
Tremfya 100 mg in 1 mL Auto-Injector
(Atom ID: 10825898)
SYPrescribable
Synonym (SY):
Tremfya 100 mg per 1 mL Auto-Injector
(Atom ID: 10825900)
Patient Education
Guselkumab Injection
Guselkumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults whose psoriasis is too severe to be treated by topical medications alone. It is also used alone or in combination with other medications to treat psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin) in adults. Guselkumab injection is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.
[Learn More]
* Please review the disclaimer below.